Harrow Health (HROW) Misses Q4 EPS by 23c

Harrow Health (NASDAQ: HROW) reported Q4 EPS of ($0.27), $0.23 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $19.35 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Prenetics Global (PRE) Tops Q2 EPS by 18c